Selected research
Market Structure
Global Pet Dog Parasite Prevention and Control Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pet Dog Parasite Prevention and Control market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pet Dog Parasite Prevention and Control is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pet Dog Parasite Prevention and Control is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Dog Parasite Prevention and Control is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pet Dog Parasite Prevention and Control is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Dog Parasite Prevention and Control include Boehringer Ingelheim, Chanelle Pharma, Dechra Pharmaceuticals, Elanco, Vetoquinol, Virbac, Bayer, Merck Animal Health and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pet Dog Parasite Prevention and Control market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pet Dog Parasite Prevention and Control and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pet Dog Parasite Prevention and Control sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Dog Parasite Prevention and Control market size, projected growth trends, production technologies, key applications, and end-use industries.
Pet Dog Parasite Prevention and Control Segment by Company
Boehringer Ingelheim
Chanelle Pharma
Dechra Pharmaceuticals
Elanco
Vetoquinol
Virbac
Bayer
Merck Animal Health
Zoetis
Pet Dog Parasite Prevention and Control Segment by Type
Injection Medication
Topical Medication
Oral Medication
Pet Dog Parasite Prevention and Control Segment by Application
Large Dog
Small Dog
Medium Dog
Pet Dog Parasite Prevention and Control Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Dog Parasite Prevention and Control market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Dog Parasite Prevention and Control and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Dog Parasite Prevention and Control.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pet Dog Parasite Prevention and Control market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Dog Parasite Prevention and Control manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Dog Parasite Prevention and Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pet Dog Parasite Prevention and Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Medication
- Topical Medication
- Oral Medication
Applications
- Large Dog
- Small Dog
- Medium Dog
Companies covered
- Boehringer Ingelheim
- Chanelle Pharma
- Dechra Pharmaceuticals
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck Animal Health
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pet Dog Parasite Prevention and Control Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pet Dog Parasite Prevention and Control Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pet Dog Parasite Prevention and Control Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pet Dog Parasite Prevention and Control Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pet Dog Parasite Prevention and Control Market Dynamics
- 2.1 Pet Dog Parasite Prevention and Control Industry Trends
- 2.2 Pet Dog Parasite Prevention and Control Industry Drivers
- 2.3 Pet Dog Parasite Prevention and Control Industry Opportunities and Challenges
- 2.4 Pet Dog Parasite Prevention and Control Industry Restraints
3 Pet Dog Parasite Prevention and Control Market by Manufacturers
- 3.1 Global Pet Dog Parasite Prevention and Control Revenue by Manufacturers (2021-2026)
- 3.2 Global Pet Dog Parasite Prevention and Control Sales by Manufacturers (2021-2026)
- 3.3 Global Pet Dog Parasite Prevention and Control Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pet Dog Parasite Prevention and Control Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Dog Parasite Prevention and Control Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pet Dog Parasite Prevention and Control Manufacturers, Product Type & Application
- 3.7 Global Pet Dog Parasite Prevention and Control Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Dog Parasite Prevention and Control Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Dog Parasite Prevention and Control Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Dog Parasite Prevention and Control Tier 1, Tier 2, and Tier 3
4 Pet Dog Parasite Prevention and Control Market by Type
- 4.1 Pet Dog Parasite Prevention and Control Type Introduction
- 4.1.1 Injection Medication
- 4.1.2 Topical Medication
- 4.1.3 Oral Medication
- 4.2 Global Pet Dog Parasite Prevention and Control Sales by Type
- 4.2.1 Global Pet Dog Parasite Prevention and Control Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pet Dog Parasite Prevention and Control Sales by Type (2021-2032)
- 4.2.3 Global Pet Dog Parasite Prevention and Control Sales Market Share by Type (2021-2032)
- 4.3 Global Pet Dog Parasite Prevention and Control Revenue by Type
- 4.3.1 Global Pet Dog Parasite Prevention and Control Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pet Dog Parasite Prevention and Control Revenue by Type (2021-2032)
- 4.3.3 Global Pet Dog Parasite Prevention and Control Revenue Market Share by Type (2021-2032)
5 Pet Dog Parasite Prevention and Control Market by Application
- 5.1 Pet Dog Parasite Prevention and Control Application Introduction
- 5.1.1 Large Dog
- 5.1.2 Small Dog
- 5.1.3 Medium Dog
- 5.2 Global Pet Dog Parasite Prevention and Control Sales by Application
- 5.2.1 Global Pet Dog Parasite Prevention and Control Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pet Dog Parasite Prevention and Control Sales by Application (2021-2032)
- 5.2.3 Global Pet Dog Parasite Prevention and Control Sales Market Share by Application (2021-2032)
- 5.3 Global Pet Dog Parasite Prevention and Control Revenue by Application
- 5.3.1 Global Pet Dog Parasite Prevention and Control Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pet Dog Parasite Prevention and Control Revenue by Application (2021-2032)
- 5.3.3 Global Pet Dog Parasite Prevention and Control Revenue Market Share by Application (2021-2032)
6 Global Pet Dog Parasite Prevention and Control Sales by Region
- 6.1 Global Pet Dog Parasite Prevention and Control Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pet Dog Parasite Prevention and Control Sales by Region (2021-2032)
- 6.2.1 Global Pet Dog Parasite Prevention and Control Sales by Region (2021-2026)
- 6.2.2 Global Pet Dog Parasite Prevention and Control Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pet Dog Parasite Prevention and Control Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pet Dog Parasite Prevention and Control Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pet Dog Parasite Prevention and Control Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pet Dog Parasite Prevention and Control Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pet Dog Parasite Prevention and Control Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pet Dog Parasite Prevention and Control Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pet Dog Parasite Prevention and Control Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pet Dog Parasite Prevention and Control Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pet Dog Parasite Prevention and Control Revenue by Region
- 7.1 Global Pet Dog Parasite Prevention and Control Revenue by Region
- 7.1.1 Global Pet Dog Parasite Prevention and Control Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pet Dog Parasite Prevention and Control Revenue by Region (2021-2026)
- 7.1.3 Global Pet Dog Parasite Prevention and Control Revenue by Region (2027-2032)
- 7.1.4 Global Pet Dog Parasite Prevention and Control Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pet Dog Parasite Prevention and Control Revenue (2021-2032)
- 7.2.2 North America Pet Dog Parasite Prevention and Control Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pet Dog Parasite Prevention and Control Revenue (2021-2032)
- 7.3.2 Europe Pet Dog Parasite Prevention and Control Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pet Dog Parasite Prevention and Control Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pet Dog Parasite Prevention and Control Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pet Dog Parasite Prevention and Control Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pet Dog Parasite Prevention and Control Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Information
- 8.1.2 Boehringer Ingelheim Business Overview
- 8.1.3 Boehringer Ingelheim Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Boehringer Ingelheim Pet Dog Parasite Prevention and Control Product Portfolio
- 8.1.5 Boehringer Ingelheim Recent Developments
- 8.2 Chanelle Pharma
- 8.2.1 Chanelle Pharma Company Information
- 8.2.2 Chanelle Pharma Business Overview
- 8.2.3 Chanelle Pharma Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Chanelle Pharma Pet Dog Parasite Prevention and Control Product Portfolio
- 8.2.5 Chanelle Pharma Recent Developments
- 8.3 Dechra Pharmaceuticals
- 8.3.1 Dechra Pharmaceuticals Company Information
- 8.3.2 Dechra Pharmaceuticals Business Overview
- 8.3.3 Dechra Pharmaceuticals Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dechra Pharmaceuticals Pet Dog Parasite Prevention and Control Product Portfolio
- 8.3.5 Dechra Pharmaceuticals Recent Developments
- 8.4 Elanco
- 8.4.1 Elanco Company Information
- 8.4.2 Elanco Business Overview
- 8.4.3 Elanco Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Elanco Pet Dog Parasite Prevention and Control Product Portfolio
- 8.4.5 Elanco Recent Developments
- 8.5 Vetoquinol
- 8.5.1 Vetoquinol Company Information
- 8.5.2 Vetoquinol Business Overview
- 8.5.3 Vetoquinol Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Vetoquinol Pet Dog Parasite Prevention and Control Product Portfolio
- 8.5.5 Vetoquinol Recent Developments
- 8.6 Virbac
- 8.6.1 Virbac Company Information
- 8.6.2 Virbac Business Overview
- 8.6.3 Virbac Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Virbac Pet Dog Parasite Prevention and Control Product Portfolio
- 8.6.5 Virbac Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Pet Dog Parasite Prevention and Control Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 Merck Animal Health
- 8.8.1 Merck Animal Health Company Information
- 8.8.2 Merck Animal Health Business Overview
- 8.8.3 Merck Animal Health Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Merck Animal Health Pet Dog Parasite Prevention and Control Product Portfolio
- 8.8.5 Merck Animal Health Recent Developments
- 8.9 Zoetis
- 8.9.1 Zoetis Company Information
- 8.9.2 Zoetis Business Overview
- 8.9.3 Zoetis Pet Dog Parasite Prevention and Control Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Zoetis Pet Dog Parasite Prevention and Control Product Portfolio
- 8.9.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pet Dog Parasite Prevention and Control Value Chain Analysis
- 9.1.1 Pet Dog Parasite Prevention and Control Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pet Dog Parasite Prevention and Control Production Mode & Process
- 9.2 Pet Dog Parasite Prevention and Control Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pet Dog Parasite Prevention and Control Distributors
- 9.2.3 Pet Dog Parasite Prevention and Control Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst